Uber has a new system that allows physician offices to book rides for patients up to 30 days in advance.

These are the top 10 medical innovations expected to be seen in 2018.

The findings may help to better characterize normative development and altered patterns of brain activity that may serve as biomarkers for neurological conditions.

The CDC has updated the US national estimate of epilepsy prevalence and estimates 3.4 million people are affected by epilepsy.

Ketamine was found to alleviate a number of pain-related conditions, and a number of clinical trials investigating its efficacy are ongoing.

Jessica Karl, PA-C, of Rush University Medical Center in Chicago, discusses her research on the utility and feasibility of deep brain stimulation in patients with Huntington’s disease. Scroll below the video for the full transcript.

Jaime Hatcher-Martin, MD, PhD, a movement disorders specialist at Emory University Hospital and the founder of Emory’s movement disorders telemedicine clinic, shares her personal experience with telemedicine and provides some guidance for clinicians who might be interested in exploring this treatment option to improve their patients’ access to care. Scroll below the video to read the full transcript.

Kara Smith, MD, a movement disorders specialist at UMass Memorial Medical Center and an assistant professor at the University of Massachusetts Medical School, both in Worcester, discusses how a brief free speech sample might be used to calculate a patient’s cognitive and motor scores. Scroll below the video to read the full transcript.

Joohi Jimenez-Shahed, MD, discusses her research on the use of deutetrabenazine for the treatment of tardive dyskinesia in patients taking concomitant antipsychotics or neuroleptics. Scroll below the video for the full transcript.

Jori Fleisher, MD, MSCE, of New York University School of Medicine, discusses her research on an interdisciplinary home visit program for patients with advanced Parkinson’s disease. Scroll below the video for the full transcript.

New research from the American Heart and American Stroke Associations found that many Americans don’t know the symptoms of stroke.

Findings from a new study suggest that engaging in stroke prevention strategies may help reduce the risk of dementia.

Anup Patel, MD, of Nationwide Children’s Hospital and The Ohio State University School of Medicine, discusses findings from a dose-ranging study of cannabidiol for the treatment of drop seizures in Lennox-Gastaut syndrome. Scroll to below the video for a full text transcript of Dr Patel’s interview.

Cynthia Harden, MD, lead author of the new SUDEP guidelines, discusses the development process and what she hopes clinicians will take away from the guidance. Scroll to below the video for a full text transcript of Dr Harden’s interview.

Dr Pamela Rist, of Harvard Medical School, discusses her research in women with migraine and hypertension at the 2017 American Academy of Neurology Annual Meeting in Boston, MA. Scroll to below the video for a full text transcript of Dr Rist’s interview.

With nearly $800 billion in health care costs spent annually on neurological disorders, researchers are calling for more funding for research as the US population ages.

Researchers found that people who slept 9 or more hours per night were at an increased risk of dementia.

New findings suggest that dysregulation of mitochondrial DNA homeostasis may be a key factor in the pathogenesis of neuronal loss in people with Parkinson’s disease.